Vericel VCEL
$
Relative Strength Index (RSI)
- The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. It is typically used to identify overbought or oversold conditions in financial markets.
- The RSI is calculated using the following formula:
RSI = 100 - (100 / (1 + RS))
Where RS is the ratio of the average gains to the average losses over a specified period.
- The default time period used is 14 days.
- RSI values range between 0 and 100.
RSI values above 70 are considered overbought (indicating a potentially opportune time to sell)
RSI values below 30 are considered oversold (indicating a potentially opportune time to buy)
RSI is not a perfect indicator and should be used in conjunction with other technical analysis tools, this is for informational purposes only and is not a substitute for professional financial advice.
Key Insights
Vericel (VCEL) Core Market Data and Business Metrics
Latest Closing Price
$43.085Price-Earnings Ratio
215.42Total Outstanding Shares
48.60 Million SharesDividend
No dividendSIC Description
Biological Products, (no Disgnostic Substances)Primary Exchange
NASDAQHeadquarters
64 Sidney St., Cambridge, MA, 02139
Historical Stock Splits
If you bought 20 shares of VCEL before October 16, 2013, you'd have 1 share today.
| Execution Date | Split Amount |
|---|---|
| October 16, 2013 | 1-for-20 (Reverse Split) |
Cash Flow Statement
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Net Cash Flow, Continuing | $-1.82 Million |
| Net Cash Flow | $-1.82 Million |
| Net Cash Flow From Investing Activities | $-79.03 Million |
| Net Cash Flow From Investing Activities, Continuing | $-79.03 Million |
| Net Cash Flow From Financing Activities | $19.05 Million |
| Net Cash Flow From Financing Activities, Continuing | $19.05 Million |
Income Statement
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Income/Loss From Continuing Operations After Tax | $10.36 Million |
| Operating Income/Loss | $4.52 Million |
| Benefits Costs and Expenses | $226.71 Million |
| Operating Expenses | $167.59 Million |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0 |
| Basic Earnings Per Share | $0.21 |
Comprehensive Income
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Comprehensive Income/Loss Attributable To Parent | $10.47 Million |
| Other Comprehensive Income/Loss | $10.47 Million |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0 |
| Comprehensive Income/Loss | $10.47 Million |
Balance Sheet
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Current Liabilities | $50.29 Million |
| Equity Attributable To Noncontrolling Interest | $0 |
| Current Assets | $212.78 Million |
| Wages | $3.27 Million |
| Equity Attributable To Parent | $291.97 Million |
| Inventory | $17.37 Million |
Historical Dividends
| Announcement Date | Payment Date | Record Date | Amount | Frequency |
|---|---|---|---|---|
| No historical dividends | ||||